Preincubation of breast cancer cells with an anti-ANX2 antibody or angiostatin, a well-characterized ANX2 inhibitor, significantly impaired PLA generation and consequently reduced cancer cell invasion and migration [103]. This evidence concerns the gene ANXA2 and breast carcinoma.